ProstaLund Valuation
| PLUN Stock | SEK 9.00 2.00 28.57% |
At this time, the company appears to be fairly valued. ProstaLund AB holds a recent Real Value of kr8.7 per share. The prevailing price of the company is kr9.0. Our model determines the value of ProstaLund AB from analyzing the company fundamentals such as Return On Equity of -0.25, shares outstanding of 57.19 M, and Operating Margin of (0.59) % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that ProstaLund's price fluctuation is slightly risky at this time. Calculation of the real value of ProstaLund AB is based on 3 months time horizon. Increasing ProstaLund's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
ProstaLund's intrinsic value may or may not be the same as its current market price of 9.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.0 | Real 8.7 | Hype 9.0 |
The intrinsic value of ProstaLund's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ProstaLund's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ProstaLund AB helps investors to forecast how ProstaLund stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProstaLund more accurately as focusing exclusively on ProstaLund's fundamentals will not take into account other important factors: ProstaLund Total Value Analysis
ProstaLund AB is at this time anticipated to have takeover price of 215.81 M with market capitalization of 248.19 M, debt of 4 M, and cash on hands of 19.11 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ProstaLund fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
215.81 M | 248.19 M | 4 M | 19.11 M |
ProstaLund Investor Information
About 51.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.17. ProstaLund AB had not issued any dividends in recent years. The entity had 40:1 split on the 27th of September 2024. Based on the measurements of operating efficiency obtained from ProstaLund's historical financial statements, ProstaLund AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.ProstaLund Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ProstaLund has an asset utilization ratio of 39.27 percent. This implies that the Company is making kr0.39 for each dollar of assets. An increasing asset utilization means that ProstaLund AB is more efficient with each dollar of assets it utilizes for everyday operations.ProstaLund Ownership Allocation
ProstaLund owns a total of 57.19 Million outstanding shares. ProstaLund has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.ProstaLund Profitability Analysis
The company reported the revenue of 17.07 M. Net Loss for the year was (7.88 M) with profit before overhead, payroll, taxes, and interest of 14.68 M.About ProstaLund Valuation
The stock valuation mechanism determines ProstaLund's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of ProstaLund AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of ProstaLund. We calculate exposure to ProstaLund's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ProstaLund's related companies.8 Steps to conduct ProstaLund's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ProstaLund's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ProstaLund's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ProstaLund's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ProstaLund's revenue streams: Identify ProstaLund's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ProstaLund's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ProstaLund's growth potential: Evaluate ProstaLund's management, business model, and growth potential.
- Determine ProstaLund's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ProstaLund's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for ProstaLund Stock Analysis
When running ProstaLund's price analysis, check to measure ProstaLund's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProstaLund is operating at the current time. Most of ProstaLund's value examination focuses on studying past and present price action to predict the probability of ProstaLund's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProstaLund's price. Additionally, you may evaluate how the addition of ProstaLund to your portfolios can decrease your overall portfolio volatility.